The sad story of Vioxx, and what we should learn from it

Cleve Clin J Med. 2004 Dec;71(12):933-4, 936, 938-9. doi: 10.3949/ccjm.71.12.933.
No abstract available

MeSH terms

  • Arthritis, Rheumatoid / drug therapy
  • Drug Approval*
  • Drug Industry*
  • Humans
  • Lactones / adverse effects*
  • Myocardial Infarction / chemically induced
  • Product Surveillance, Postmarketing*
  • Randomized Controlled Trials as Topic
  • Stroke / chemically induced
  • Sulfones / adverse effects*
  • United States
  • United States Food and Drug Administration*

Substances

  • Lactones
  • Sulfones
  • rofecoxib